ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC14969-10mM (in 1mL DMSO) |
|
57852-57-0 |
Idarubicin HCl
|
0 | C26H27NO9.HCl | |
GC14969-50mg |
|
57852-57-0 |
Idarubicin HCl
|
0 | C26H27NO9.HCl | |
GC14969-10mg |
|
57852-57-0 |
Idarubicin HCl
|
0 | C26H27NO9.HCl | |
GC14969-5mg |
|
57852-57-0 |
Idarubicin HCl
|
0 | C26H27NO9.HCl | |
GC14968-10mM (in 1mL DMSO) |
|
81161-17-3 |
Esmolol HCl
|
0 | C16H25NO4.HCl | |
GC14968-50mg |
|
81161-17-3 |
Esmolol HCl
|
0 | C16H25NO4.HCl | |
GC14967-10mg |
|
667463-95-8 |
MeBIO
|
0 | C17H12BrN3O2 | |
GC14967-5mg |
|
667463-95-8 |
MeBIO
|
0 | C17H12BrN3O2 | |
GC14967-1mg |
|
667463-95-8 |
MeBIO
|
0 | C17H12BrN3O2 | |
GC14966-25mg |
|
76135-31-4 |
8-Hydroxy-DPAT hydrobromide
|
0 | C16H25NO.HBr | |
GC14966-10mg |
|
76135-31-4 |
8-Hydroxy-DPAT hydrobromide
|
0 | C16H25NO.HBr | |
GC14966-5mg |
|
76135-31-4 |
8-Hydroxy-DPAT hydrobromide
|
0 | C16H25NO.HBr | |
GC14965-100mg |
|
150403-97-7 |
Ethyl-L-NIO (hydrochloride)
|
0 | C9H19N3O2 • HCl | |
GC14965-50mg |
|
150403-97-7 |
Ethyl-L-NIO (hydrochloride)
|
0 | C9H19N3O2 • HCl | |
GC14965-10mg |
|
150403-97-7 |
Ethyl-L-NIO (hydrochloride)
|
0 | C9H19N3O2 • HCl | |
GC14965-5mg |
|
150403-97-7 |
Ethyl-L-NIO (hydrochloride)
|
0 | C9H19N3O2 • HCl | |
GC14962-10mM (in 1mL DMSO) |
|
522-48-5 |
Tetrahydrozoline HCl
|
0 | C13H16N2.HCl | |
GC14962-50mg |
|
522-48-5 |
Tetrahydrozoline HCl
|
0 | C13H16N2.HCl | |
GC14961-200mg |
|
69-74-9 |
Cytarabine hydrochloride
|
0 | C9H14ClN3O5 | |
GC14961-1g |
|
69-74-9 |
Cytarabine hydrochloride
|
0 | C9H14ClN3O5 | |